http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018073632-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c2ceed5396f5184832a91a6ac4b3e37 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43ffe13527d13464a1925b155be2d4df |
| publicationDate | 2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2018073632-A1 |
| titleOfInvention | A method of manufacturing a solution of nsaid nanoparticles |
| abstract | A method of manufacturing a solution of NSAID nanoparticles, where a propionic acid derivative NSAID is dissolved in an organic solvent, and at least one dispersing agents is dissolved in water, then the organic solution is added to the aqueous solution and the obtained mixture is homogenised until homogenous solution is obtained. Preferably the organic solvent is ethanol, and the dispersing agent is gelatine, starch and/or lecithin. |
| priorityDate | 2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.